Missouri Southern State University throwers Cedric Pearson and Dailynn VanDeren were honored by the MIAA this week. Pearson ...

HealthDay News — Once-daily oral zasocitinib (TAK-279), an oral tyrosine kinase 2 (TYK2) inhibitor, provides a durable response in adults with moderate-to-severe plaque psoriasis (PsO), according to a ...

JOPLIN, Mo. (KOAM) -- On Tuesday, Missouri Southern's Cedric Pearson and Dailynn VanDeren swept the MIAA Field Athlete of the ...

The Princeton Symphony Orchestra (PSO) has announced the appointment of Tomás García to the position of Georg and Joyce ...

CEO of DHL Express. He is a veteran of the express industry, having joined DHL in the Middle East in 1986. He has held senior ...

The music has the feel of classic 1960s soul—timeless songs that sound like they could have been written 30 or 40 years ago.

Agusan del Sur Governor Santiago Cane Jr. leads a press conference on Monday, April 6, 2026, regarding updates for the Palarong Pambansa 2026, joined by Department of Education Caraga Regional ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Once-daily oral zasocitinib for moderate to severe plaque psoriasis demonstrated rapid and durable skin clearance and a ...